Papers
7
Total Citations
81
H-Index
5
About
Dr. Sara Al-Madhi is a pioneering surgeon whose work is reshaping the landscape of minimally invasive liver and pancreatic surgery, with a particular focus on the transformative potential of robotic platforms. Her research systematically addresses the critical question of whether robotic surgery offers tangible advantages over conventional laparoscopic approaches. In a highly cited 2022 meta-analysis (22 citations), she demonstrated that robotic liver surgery can enhance R0 resection rates for malignancies, a pivotal finding for oncologic outcomes. Dr. Al-Madhi is also a leader in surgical education; her "Robotic Curriculum for young Surgeons" (RoCS) study (10 citations) proves that structured robotic training can be safely integrated into clinical practice without compromising patient outcomes, directly addressing a key barrier to technology adoption. Her work on the LiMAx test (20 citations) provides objective criteria for patient selection, aiming to reduce the risk of post-hepatectomy liver failure. With over 80 citations across her portfolio, including a landmark learning curve analysis of 100 robotic liver resections, Dr. Al-Madhi is not only advancing technical frontiers but also building the evidence base and training infrastructure necessary to make robotic surgery a safe, standard option for patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2Learning curve analysis of 100 consecutive robotic liver resections20 citations · 2025
- 3The LiMAx Test as Selection Criteria in Minimally Invasive Liver Surgery20 citations · 2022
- 4
- 5
- 6
- 7